Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
Cytotoxic drugs used in chemotherapy of leukemias and solid tumors cause apoptosis in target cells1,2. In lymphoid cells the CD95 (APO-1/Fas)/CD95 ligand (CD95-L) system is a key regulator of apoptosis3-6. Here we describe that doxorbicin induces apoptosis via the CD95/CD95-L system in human leukemi...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
01 May 1996
|
| In: |
Nature medicine
Year: 1996, Jahrgang: 2, Heft: 5, Pages: 574-577 |
| ISSN: | 1546-170X |
| DOI: | 10.1038/nm0596-574 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nm0596-574 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nm0596-574 
|
| Verfasserangaben: | Claudia Friesen, Ingrid Herr, Peter H. Krammer, Klaus-Michael Debatin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1906333041 | ||
| 003 | DE-627 | ||
| 005 | 20241205181940.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241021s1996 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/nm0596-574 |2 doi | |
| 035 | |a (DE-627)1906333041 | ||
| 035 | |a (DE-599)KXP1906333041 | ||
| 035 | |a (OCoLC)1475316211 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Friesen, Claudia |e VerfasserIn |0 (DE-588)1345594275 |0 (DE-627)1906333475 |4 aut | |
| 245 | 1 | 0 | |a Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells |c Claudia Friesen, Ingrid Herr, Peter H. Krammer, Klaus-Michael Debatin |
| 264 | 1 | |c 01 May 1996 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.10.2024 | ||
| 520 | |a Cytotoxic drugs used in chemotherapy of leukemias and solid tumors cause apoptosis in target cells1,2. In lymphoid cells the CD95 (APO-1/Fas)/CD95 ligand (CD95-L) system is a key regulator of apoptosis3-6. Here we describe that doxorbicin induces apoptosis via the CD95/CD95-L system in human leukemia T-cell lines. Doxorubicin-induced apoptosis was completely blocked by inhibition of gene expression and protein synthesis. Also, doxorbicin strongly stimulated CD95-L messenger RNA expression in vitro at concentrations relevant for therapy in vivo. CEM and Jurkat cells resistant to CD95-mediated apoptosis were also resistant to doxorbicin-induced apoptosis. Furthermore, doxorbicin-induced apoptosis was inhibited by blocking F(ab′)2 anti-APO-1 (anti-CD95) antibody fragments. Expression of CD95-L mRNA and protein in vitro was also stimulated by other cytotoxic drugs such as methotrexate. The finding that apoptosis caused by anticancer drugs may be mediated via the CD95 system provides a new molecular insight into resistance and sensitivity toward chemotherapy in malignancies. | ||
| 650 | 4 | |a Biomedicine | |
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a general | |
| 650 | 4 | |a Infectious Diseases | |
| 650 | 4 | |a Metabolic Diseases | |
| 650 | 4 | |a Molecular Medicine | |
| 650 | 4 | |a Neurosciences | |
| 700 | 1 | |a Herr, Ingrid |e VerfasserIn |0 (DE-588)114884242 |0 (DE-627)691233276 |0 (DE-576)168702436 |4 aut | |
| 700 | 1 | |a Krammer, Peter H. |d 1946- |e VerfasserIn |0 (DE-588)121766373 |0 (DE-627)081520255 |0 (DE-576)292873417 |4 aut | |
| 700 | 1 | |a Debatin, Klaus-Michael |d 1952- |e VerfasserIn |0 (DE-588)109442288 |0 (DE-627)507956451 |0 (DE-576)289642809 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature medicine |d [New York, NY] : Springer Nature, 1995 |g 2(1996), 5, Seite 574-577 |h Online-Ressource |w (DE-627)301511640 |w (DE-600)1484517-9 |w (DE-576)288571274 |x 1546-170X |7 nnas |a Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells |
| 773 | 1 | 8 | |g volume:2 |g year:1996 |g number:5 |g pages:574-577 |g extent:4 |a Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells |
| 856 | 4 | 0 | |u https://doi.org/10.1038/nm0596-574 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/nm0596-574 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241021 | ||
| 993 | |a Article | ||
| 994 | |a 1996 | ||
| 998 | |g 109442288 |a Debatin, Klaus-Michael |m 109442288:Debatin, Klaus-Michael |d 910000 |d 910500 |e 910000PD109442288 |e 910500PD109442288 |k 0/910000/ |k 1/910000/910500/ |p 4 |y j | ||
| 998 | |g 121766373 |a Krammer, Peter H. |m 121766373:Krammer, Peter H. |d 50000 |e 50000PK121766373 |k 0/50000/ |p 3 | ||
| 998 | |g 114884242 |a Herr, Ingrid |m 114884242:Herr, Ingrid |p 2 | ||
| 998 | |g 1345594275 |a Friesen, Claudia |m 1345594275:Friesen, Claudia |d 910000 |d 910500 |e 910000PF1345594275 |e 910500PF1345594275 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1906333041 |e 4600507150 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells","title_sort":"Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells"}],"person":[{"roleDisplay":"VerfasserIn","display":"Friesen, Claudia","role":"aut","family":"Friesen","given":"Claudia"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Herr, Ingrid","given":"Ingrid","family":"Herr"},{"roleDisplay":"VerfasserIn","display":"Krammer, Peter H.","role":"aut","family":"Krammer","given":"Peter H."},{"role":"aut","display":"Debatin, Klaus-Michael","roleDisplay":"VerfasserIn","given":"Klaus-Michael","family":"Debatin"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 21.10.2024"],"language":["eng"],"recId":"1906333041","origin":[{"dateIssuedKey":"1996","dateIssuedDisp":"01 May 1996"}],"id":{"doi":["10.1038/nm0596-574"],"eki":["1906333041"]},"name":{"displayForm":["Claudia Friesen, Ingrid Herr, Peter H. Krammer, Klaus-Michael Debatin"]},"physDesc":[{"extent":"4 S."}],"relHost":[{"id":{"zdb":["1484517-9"],"eki":["301511640"],"issn":["1546-170X"]},"origin":[{"dateIssuedDisp":"2017-","publisher":"Springer Nature ; Nature America Inc.","dateIssuedKey":"2017","publisherPlace":"[New York, NY] ; New York, NY"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Nature medicine","title_sort":"Nature medicine"}],"language":["eng"],"recId":"301511640","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cellsNature medicine","note":["Gesehen am 24. Juli 2018"],"part":{"year":"1996","pages":"574-577","issue":"5","volume":"2","text":"2(1996), 5, Seite 574-577","extent":"4"},"pubHistory":["1.1995 -"]}]} | ||
| SRT | |a FRIESENCLAINVOLVEMEN0119 | ||